Case Study of Drug Resistance in Two Children: Treatment Summary for Both Cases

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 135 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
The page below is a sample from the LabCE course Tracking Antibiotic-Resistant Tuberculosis. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Tracking Antibiotic-Resistant Tuberculosis (online CE course)
Case Study of Drug Resistance in Two Children: Treatment Summary for Both Cases

In the two cases discussed, treatment with LNZ and MOX appeared successful, despite a lack of official recommendation for both drugs in treating children. Second-line drugs have a high risk of adverse effects, such as bone marrow suppression and peripheral/optic neuropathy, as well as cutaneous, gastrointestinal, central nervous system (CNS), cardiac, and musculoskeletal damage. In the cases presented, the guardians understood the need to proceed aggressively and gave approval to use the drugs. The children were carefully monitored for complications and treatment failure.